Publications by authors named "Hugo Jourdain"

Claim this Profile
P
PD-L1 inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: a French nationwide cohort study.
Hugo Jourdain, Nicolas Albin, Adrien Monard, David Desplas, Mahmoud Zureik

Lancet Reg Health Eur· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies.
Hugo Jourdain, Antonio Di Meglio, Imène Mansouri, David Desplas, Mahmoud Zureik

Lancet Reg Health Eur· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasectomy Procedures on the Rise in France From 2010 to 2022.
Noémie Roland, Hugo Jourdain, Alain Weill, Cédric Lebâcle, Mahmoud Zureik

Perspect Sex Reprod Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study.
Duc Binh Phan, Hugo Jourdain, Miguel Angel Descalzo-Gallego, Alicia González-Quesada, Mahmoud Zureik

Br J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study.
Nadia Haddy, Hugo Jourdain, David Desplas, Marion Bertrand, Marie-Joelle Jabagi

BioDrugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian, Mahmoud Zureik

World J Pediatr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric Cancer in a Real-World Setting: A Nationwide Cohort Study.
Hugo Jourdain, Nicolas Albin, Adrien Monard, David Desplas, Mahmoud Zureik

Clin Transl Gastroenterol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System.
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian, Mahmoud Zureik

RMD Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
Duc Binh Phan, Hugo Jourdain, Alicia González-Quesada, Mahmoud Zureik, Raquel Rivera-Díaz

BMJ Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System.
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian, Mahmoud Zureik

BioDrugs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview.
Sophie Billioti de Gage, Hugo Jourdain, David Desplas, Rosemary Dray-Spira

Therapie· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System.
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian, Mahmoud Zureik

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study.
Hugo Jourdain, Sophie Billioti de Gage, David Desplas, Rosemary Dray-Spira

Lancet Public Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis